ONEMEDNET CORPORATION Retained Earnings
ONEMEDNET CORPORATION (ONMD) had Retained Earnings of -$109.00 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$109.00M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$106.82M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$104.37M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$101.23M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$109.00M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$106.82M S-1/A · filed 2026-07-08 | |
| 2025-12-31 | -$104.37M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$101.23M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$100.49M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | -$103.47M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$101.57M S-1/A · filed 2026-07-08 | |
| 2024-09-30 | -$99.20M 10-Q · filed 2024-12-17 | |
| 2024-06-30 | -$97.14M 10-Q · filed 2024-12-11 | |
| 2024-03-31 | -$93.55M 10-Q · filed 2024-12-05 | |
| 2023-12-31 | -$91.44M 10-K · filed 2025-04-15 | -$55.08M 10-K · filed 2024-04-09 |
| 2023-09-30 | -$88.90M 8-K/A · filed 2024-11-22 | -$36.83M 10-Q · filed 2023-11-20 |
| 2023-06-30 | -$11.72M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$11.72M 10-Q · filed 2023-05-19 | |
| 2022-12-31 | -$57.66M 8-K/A · filed 2024-11-22 | -$11.63M 10-K · filed 2023-03-31 |
| 2022-09-30 | -$8.45M 10-Q · filed 2022-11-18 | |
| 2022-06-30 | -$6.61M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$6.41M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | -$8.61M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$8.15M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$9.44M 10-Q · filed 2021-11-15 | $4.31M 10-Q · filed 2021-08-16 |
| 2021-05-11 | -$13.76M 10-Q · filed 2021-11-15 | |
| 2021-03-31 | -$845.00 10-Q/A · filed 2021-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |